Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States미국 중서부의 공립학교 교직원에서 항-SARS-CoV-2 IgG 항체의 혈청 유병률Research Article Published on 2021-06-102022-09-12 Journal: PLoS ONE [Category] MERS, SARS, 진단, [키워드] 95% CI Abbott acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis anti-SARS-CoV-2 IgG antibody antibody Antibody test attributes baseline cause Contact Contact tracing coronavirus Corporation Correcting correlation correlations COVID-19 credible interval cross-sectional demographics diagnosed with COVID-19 employment enrolled exposure to herd immunity Immunity increase in individual lack Lake location Logistic regression measure multivariable logistic regression parameters participant positive Positive test presence of antibody Primary outcome SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection SARS-CoV-2 seroprevalence School secondary outcome Secondary outcomes Seropositivity Seroprevalence severe acute respiratory syndrome Coronavirus social distancing Symptom tested the United State Travel United State United States USA [DOI] 10.1371/journal.pone.0243676 PMC 바로가기 [Article Type] Research Article
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands일반 인구에서 SARS-CoV-2 감염의 무증상 비율 추정: 네덜란드의 전국 혈청 조사 데이터 분석Covid-19 Published on 2021-06-102022-09-10 Journal: European Journal of Epidemiology [Category] MERS, SARS, 바이오마커, 진단, [키워드] 95% CI age approach Asymptomatic Asymptomatic disease attributable risk calculated caused conducted containment strategies COVID-19 COVID-19 symptoms ECDC ENhance estimate implementation infected with SARS-CoV-2 Infection Netherland Netherlands open positive proportion public health Relative risk reported symptom reported symptoms Research Result risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positive person serological Seropositivity Serosurvey supplementary material Symptom test results The Netherlands Virological was used without symptom [DOI] 10.1007/s10654-021-00768-y PMC 바로가기 [Article Type] Covid-19
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, SwitzerlandArticle Published on 2021-06-082022-10-04 Journal: Nature Communications [Category] MERS, SARS, 진단, [키워드] administration anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG antibodies Care Computational models COVID-19 pandemic Epidemiology essential worker First wave healthcare higher risk Infection limit Limited media Nurses Participants positive Prevalence PROTECT ranged recruited SARS-CoV-2 SARS-COV-2 infection Seropositivity Serosurvey Spread Switzerland tested vaccination Variation viral infection [DOI] 10.1038/s41467-021-23796-4 PMC 바로가기 [Article Type] Article
Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy이탈리아 북부의 3 차 간호 대학 병원에있는 의료 종사자들의 대규모 코호트에서 SARS-COV-2 IgG 혈청 양성과 관련된 유병률, 지속성 및 요인Observational Study Published on 2021-06-032022-09-01 Journal: Viruses [Category] MERS, 임상, 진단, [키워드] active smoker active smokers antibody Asymptomatic Care comparable Contact COVID COVID-19 COVID-19 serological testing Europe evaluate evaluated evidenced Factor Frequency Health care health care workers Health personnel highest hospital household increased risk individual Infection Italy multivariable analysis observational study occurred Odds ratio pandemic performed population surveillance positive Ratio reported risk SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection seropositive subject seropositive subjects Seropositivity Seroprevalence significant difference significant differences significantly Smokers subject surveys and questionnaires Symptom Tertiary tested Turin university worker [DOI] 10.3390/v13061064 PMC 바로가기 [Article Type] Observational Study
COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care ProfessionalsCOVID-19: 영국 치과 진료 전문가의 혈청 유병률 및 백신 반응Research Reports Published on 2021-06-022022-09-10 Journal: Journal of Dental Research [Category] MERS, SARS, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis anti–SARS-CoV-2 IgG antibodies antibody Antibody Response Antibody responses baseline Care Cohort coronavirus coronavirus disease Coronavirus disease 2019 DCPs dental dentistry Deprivation detectable enzyme-linked immunosorbent enzyme-linked immunosorbent assay estimate exposure to First wave Follow-up future infection greater Guidance health guidance Health Organization Immunological memory individual Infection Infection prevention infection with SARS-CoV-2 initial International international standard leads magnitude natural natural infection occupational exposure occurred pandemic participant Personal protective equipment Pfizer-BioNTech polymerase chain polymerase chain reaction PPE professional public health recruited reduced risk respiratory response retained risk robust SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 spike glycoprotein second wave seroepidemiological studies serological response seropositive Seropositivity Seroprevalence severe acute respiratory syndrome Coronavirus significantly higher single dose spike glycoprotein Support thought United Kingdom vaccination Vaccine was determined West World Health Organization [DOI] 10.1177/00220345211020270 PMC 바로가기 [Article Type] Research Reports
Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study암 환자에서 SARS-COV-2와 관련된 IgG 및 IgM 항체의 혈청학적 변화 평가: 코호트 혈청 유병률 연구Short Communication Published on 2021-06-012022-09-01 Journal: Asian Pacific Journal of Cancer Prevention : APJCP [Category] 진단, [키워드] age all age group all age groups anticancer Asymptomatic asymptomatic infections asymptomatic patient Cancer cancer patient Cancer patients change cohort study coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 symptom COVID-19 symptoms COVID-19 transmission COVID-19- SARS-CoV-2- cancer- oncology- asymptomatic determine diagnostic disease elevated ELISA enrolled enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Epidemic evaluated Evidence General population IgG and IgM Infection investigated morbidity morbidity and mortality outbreak pandemic spreads Patient positive Remission risk SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection Seroconversion serologic serological test Serologically serology testing Seropositivity Seroprevalence serum sample serum samples Sex the SARS-CoV-2 therapy while [DOI] 10.31557/APJCP.2021.22.6.1667 PMC 바로가기 [Article Type] Short Communication
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer암 치료를 받는 환자에서 SARS-CoV-2에 대한 BNT162b2 메신저 RNA 백신 접종 후 혈청 양성 평가Research Published on 2021-05-282022-09-12 Journal: JAMA Oncology [Category] MERS, SARS, 진단, [키워드] 95% CI accompanied active treatment age analyses Analysis analyzed anti-S Antibody Response Antibody titer anticancer Beilinson Hospital blood sample Blood samples BNT162b2 BNT162b2 vaccine Cancer center Chemotherapy cohort study comparison Comparisons conducted Control control group COVID-19 COVID-19 disease Davidoff defined develop domain Enrollment evaluate exhibited Factor finding greater healthy control healthy controls high risk higher risk IgG IgG antibodies IgG antibody IgG titer IgG titers immunoassay Immunotherapy Importance intravenous measure median men messenger Messenger RNA multivariable analyses multivariable analysis objective outcome participant Participants Patient Patients with cancer Point Primary outcome prospective cohort study receiving Relevance required Research respond Result RNA SARS-CoV 2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose second messenger secondary Secondary outcomes seropositive Seropositivity serum sample serum samples setting severe COVID-19 disease significantly significantly lower solid tumor solid tumors Study participants Support systemic therapy systemic treatment the patient therapy titers Treatment Tumor tumors vaccination vaccine dose [DOI] 10.1001/jamaoncol.2021.2155 PMC 바로가기 [Article Type] Research
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individualsArticle Published on 2021-05-242022-10-30 Journal: iScience [Category] COVID-19, [키워드] 95% confidence interval Abstract acute respiratory syndrome age Analysis antibody Antibody testing Antibody titer appear Biomarker Blood clinical care coronavirus detectable epidemic wave Health health informatics Immunity immunology individual Infection Infection control in health technology likelihood optical Pearson correlation coefficient positively correlated Public public health repeated risk SARS-CoV-2 SARS-CoV-2 seroprevalence Seropositivity Sex specimen subsequent was performed [DOI] 10.1016/j.isci.2021.102646 PMC 바로가기 [Article Type] Article
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release AssaySARS-CoV-2 감염 후 구조 단백질의 광범위한 T 세포 표적화: 자동화된 인터페론 감마 방출 분석을 사용한 T 세포 반응성의 높은 처리량 평가Immunology Published on 2021-05-202022-09-11 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료법, [키워드] Antibody titer Antigen antigens approach assessment automated body mass body mass index breadth C-terminus characteristic comparable confirmed case confirmed cases Control control subjects convalescent coronavirus disease Coronavirus disease 2019 correlated COVID-19 days post infection Elecsy Elecsys facilitate followed by fresh whole blood Gamma groups high accuracy high through put IgG immune response immune responses Infection interferon gamma interferon gamma release assay (IGRA) large cohort less magnitude membrane nucleocapsid PCR positive Protein reactivity Release Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody SCT seropositive seropositive individual Seropositivity Sex significantly specific antibodies structural protein structural proteins subject T cell T cell response T cell responses T cells targeting targets tested throughput virion virus was performed were assessed Whole blood [DOI] 10.3389/fimmu.2021.688436 PMC 바로가기 [Article Type] Immunology
Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden스웨덴 스톡홀름에서 SARS-CoV-2 전염 첫 해 동안 헌혈자와 임산부의 혈청 양성Original Article Published on 2021-05-182022-09-12 Journal: Journal of internal medicine [Category] SARS, 진단, [키워드] affecting age All participants Antibody testing approach approaches B‐cell baseline Bayesian framework blood donor Blood donors carried clinical trial clinical trials Cohort community transmission comparable competent complement Control COVID‐19 dissemination FIVE glycoprotein healthy blood donor healthy blood donors healthy donor IgG response IgG responses independent individual Infection infections information intervals Karolinska University Hospital likelihood lockdown Metadata mild infection mRNA vaccination Neutralizing antibody response neutralizing antibody responses pandemic participant Participants population immunity pregnant women Prospective Study random Randomly RBD reached receptor‐binding domain recommendations registration number Result review sampling SARS‐CoV‐2 SARS‐CoV‐2 infection SARS‐CoV‐2 spike SARS‐CoV‐2 screened second wave selected sera serology seropositive Seropositivity Seroprevalence setting study period Sweden Swedish Swedish Ethical Review Authority symptomatic tested These data titre titres trajectory Transmission trimer vaccination Vaccinations was used [DOI] 10.1111/joim.13304 PMC 바로가기 [Article Type] Original Article